Whitehawk Therapeutics (WHWK) Non Operating Income (2016 - 2021)
Whitehawk Therapeutics (WHWK) posted quarterly Non Operating Income of $363426.0 for Q2 2021, up 1706.38% year-over-year from $20119.0 in Q2 2020, and up 11870.55% quarter-over-quarter from $3036.0 in Q1 2021.
Whitehawk Therapeutics (WHWK) Non Operating Income (2016 - 2021) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Non Operating Income for 6 consecutive years, with $363426.0 the latest figure, recorded in Q2 2021.
- In Q2 2021, Non Operating Income rose 1706.38% year-over-year to $363426.0; the TTM figure through Jun 2021 stood at $1.3 million (up 94.1% YoY), while the FY2020 annual figure was $2.0 million, up 98.06% from the prior year.
- Non Operating Income rose to $363426.0 in Q2 2021 per WHWK's latest filing, from $3036.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $918953.0 in Q4 2020 and bottomed at -$236118.0 in Q1 2017.
- Historically, Non Operating Income has averaged $187645.4 across 5 years, with a median of $151470.5 in 2017.
- Annual changes were most pronounced in 2017 — Non Operating Income slumped 2297.47% — and 2021, when it surged 1706.38%.
- Whitehawk Therapeutics' Non Operating Income stood at $53829.0 in 2017, then soared by 545.73% to $347588.0 in 2018, then plunged by 39.27% to $211089.0 in 2019, then jumped by 335.34% to $918953.0 in 2020, then sank by 60.45% to $363426.0 in 2021.
- Business Quant data shows WHWK's Non Operating Income at $363426.0 in Q2 2021, $3036.0 in Q1 2021, and $918953.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 363,426.00 |
| Mar 31, 2021 | 3,036.00 |
| Dec 31, 2020 | 918,953.00 |
| Sep 30, 2020 | 9,002.00 |
| Jun 30, 2020 | 20,119.00 |
| Mar 31, 2020 | 196,270.00 |
| Dec 31, 2019 | 211,089.00 |
| Sep 30, 2019 | 239,405.00 |
| Jun 30, 2019 | 295,303.00 |
| Mar 31, 2019 | 348,468.00 |
| Dec 31, 2018 | 347,588.00 |
| Sep 30, 2018 | 339,441.00 |
| Jun 30, 2018 | 46,464.00 |
| Mar 31, 2018 | 51,116.00 |
| Dec 31, 2017 | 53,829.00 |
| Sep 30, 2017 | 106,671.00 |
| Jun 30, 2017 | 63,555.00 |
| Mar 31, 2017 | -236,118.00 |
| Dec 31, 2016 | -212,556.00 |
| Sep 30, 2016 | -140,286.00 |